Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Dev Neurosci ; 2024 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-38712701

RESUMEN

Attention deficit hyperactivity disorder (ADHD) with and without subclinical epileptogenic discharges (SED) have been suggested to negatively affect cognitive abilities of children with ADHD. The role of brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in ADHD is in need of being investigated. The aims were to evaluate the levels of serum BDNF, proBDNF and the proBDNF/BDNF ratio in addition to the potential impacts of SED on the children's cognitive abilities and the severity of ADHD. The included participants with ADHD were 30 children with normal electroencephalogram (EEG) (G1) and 30 children with SED (G2), together with 30 healthy children (G3). The cognitive abilities and severity of the disorder were evaluated. The biochemical measures were determined by ELISA. The presence of coexisting SED and nocturnal enuresis has led to a deleterious effect on cognitive processes but not on the severity. The focal epileptogenic discharge was the most common among children in G2. The levels of BDNF in Groups 1 and 2 were less than those in G3. The higher proBDNF/BDNF ratio could be related to the low BDNF levels rather than high proBDNF levels. The findings of this study highlight the importance of investigating the presence of SED and nocturnal enuresis in children with ADHD. Targeting strengthening of cognitive abilities in children with coexisting ADHD and SED is advised. The role of proBDNF in the pathophysiology of ADHD needs further investigation.

2.
J Child Neurol ; 32(1): 41-45, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27664194

RESUMEN

We conducted the present study to examine cognitive function and serum heat shock protein 70 levels among children with temporal lobe epilepsy. The Stanford-Binet Intelligence Test was carried out to examine cognitive function in 30 children with temporal lobe epilepsy and 30 controls. Serum heat shock protein 70 levels were determined with an enzyme-linked immunosorbent assay. The epilepsy group had significantly lower cognitive function testing scores and significantly higher serum heat shock protein 70 levels than the control group; there were significant negative correlations between serum heat shock protein 70 levels and short-term memory and composite scores. Children with uncontrolled seizures had significantly lower verbal reasoning scores and significantly higher serum heat shock protein 70 levels than children with controlled seizures. Children with temporal lobe epilepsy have cognitive dysfunction and elevated levels of serum heat shock protein 70, which may be considered a stress biomarker.


Asunto(s)
Cognición , Epilepsia del Lóbulo Temporal/sangre , Epilepsia del Lóbulo Temporal/psicología , Proteínas HSP70 de Choque Térmico/sangre , Factores de Edad , Edad de Inicio , Biomarcadores/sangre , Niño , Preescolar , Cognición/fisiología , Disfunción Cognitiva/sangre , Disfunción Cognitiva/etiología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Pruebas de Inteligencia , Masculino , Memoria a Corto Plazo/fisiología
3.
J Med Screen ; 23(3): 124-9, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26790708

RESUMEN

OBJECTIVES: To estimate the burden of metabolic disorders detectable by tandem mass spectrometry in Egypt, through a pilot expanded newborn screening programme at Cairo University Children's Hospital in 2008, and examining the results of 3,900 clinically at-risk children, investigated at Cairo University Children's Hospital for the same disorders over the past 7 years using the same technology. METHODS: Dried blood spots of 25,276 healthy newborns from three governorates in Upper, Middle, and Lower Egypt were screened, to give a representative sample of the Egyptian newborn population. Based on the pilot study outcomes and the results of clinically suspected children, we estimated the total birth prevalence of tandem mass spectrometry detectable metabolic disorders, and the relative frequency of several individual disorders. RESULTS: Among the healthy newborns, 13 metabolic disorder cases (five phenylketonuria [1:5,000], two methylmalonic acidemia, and isovaleric acidemia [1:12,500], one each of maple syrup urine disease, propionic acidemia, ß-ketothiolase deficiency, and primary carnitine deficiency [1:25,000]) were confirmed, giving a total birth prevalence of 1:1944 live births. Among the clinically suspected children, 235 cases were diagnosed, representing a much wider disease spectrum. CONCLUSIONS: Egypt has one of the highest reported birth prevalence rates for metabolic disorders detectable by tandem mass spectrometry. Early diagnosis and management are crucial for the survival and well-being of affected children. A nationwide NBS programme by tandem mass spectrometry is recommended.


Asunto(s)
Errores Innatos del Metabolismo/epidemiología , Tamizaje Neonatal/métodos , Evaluación de Resultado en la Atención de Salud , Egipto/epidemiología , Femenino , Humanos , Recién Nacido , Masculino , Errores Innatos del Metabolismo/diagnóstico , Proyectos Piloto , Prevalencia , Espectrometría de Masas en Tándem
4.
Cell ; 154(3): 505-17, 2013 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-23911318

RESUMEN

Purine biosynthesis and metabolism, conserved in all living organisms, is essential for cellular energy homeostasis and nucleic acid synthesis. The de novo synthesis of purine precursors is under tight negative feedback regulation mediated by adenosine and guanine nucleotides. We describe a distinct early-onset neurodegenerative condition resulting from mutations in the adenosine monophosphate deaminase 2 gene (AMPD2). Patients have characteristic brain imaging features of pontocerebellar hypoplasia (PCH) due to loss of brainstem and cerebellar parenchyma. We found that AMPD2 plays an evolutionary conserved role in the maintenance of cellular guanine nucleotide pools by regulating the feedback inhibition of adenosine derivatives on de novo purine synthesis. AMPD2 deficiency results in defective GTP-dependent initiation of protein translation, which can be rescued by administration of purine precursors. These data suggest AMPD2-related PCH as a potentially treatable early-onset neurodegenerative disease.


Asunto(s)
AMP Desaminasa/metabolismo , Atrofias Olivopontocerebelosas/metabolismo , Purinas/biosíntesis , AMP Desaminasa/química , AMP Desaminasa/genética , Animales , Tronco Encefálico/patología , Cerebelo/patología , Niño , Femenino , Guanosina Trifosfato/metabolismo , Humanos , Masculino , Ratones , Ratones Noqueados , Mutación , Células-Madre Neurales/metabolismo , Atrofias Olivopontocerebelosas/genética , Atrofias Olivopontocerebelosas/patología , Biosíntesis de Proteínas , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...